Investor
Rambam AG
Zug · Switzerland
Swiss venture studio and life science hub accelerating breakthrough therapeutics from discovery to commercialisation.
Stage
Pre-seed
Sectors
Digital Health
Cheque
Not confirmed
Invests in
5 countries
Sectors
Invests in
About
This Swiss venture studio transforms scientific breakthroughs into market-ready treatments. It operates as an integrated life science hub that connects venture capital with end-to-end program execution. The firm features a built-in contract research organisation to manage full-cycle clinical trials. Its platform is supported by artificial intelligence and computer-aided drug design. The group maintains a global network across Europe and the United States to accelerate early programs.
How to approach
Contact the firm via the email address or the provided contact form on their website.
Portfolio · 3 · tap a company to read about it